Drug Profile
GC 4702
Alternative Names: GC4702Latest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator Galera Therapeutics
- Class Small molecules
- Mechanism of Action Superoxide dismutase modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Stomatitis
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for phase-I development in Stomatitis(In volunteers) in Australia (PO, Powder)
- 28 Aug 2019 No recent reports of development identified for phase-I development in Stomatitis(In volunteers) in Australia (PO, Suspension)
- 28 Aug 2019 No recent reports of development identified for phase-I development in Stomatitis(In volunteers) in Australia (PO, Tablet)